Link to article on investing.com: https://www.investing.com/analysis/why-investors-should-track-the-prescription-drug-user-fee-act-200583708
Summary:
DUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market. Among the dozens of corporate event data points provided to our customers, Wall Street Horizon gathers PDUFA dates and content so our clients stay in the know.
Recent Content
-
US Markets Wrap: Latest in FOMC minutes; US economy resilience; consumer sentiments in the next earnings season; Magnificent Seven
-
NVIDIA In Focus: CES This Week, J.P. Morgan Healthcare Conference Next Week, February Earnings
-
NYSE TV: Expectations for Markets in New Year
-
[Infographic] Volatility Inducing Events from 2024
-
2024 YTD Dividend Announcement Trends of US and Canadian Companies
-
How Climate Risk Could Impact Investments in 2025
-
A Blockbuster Thanksgiving at the Box Office: Grab Your Popcorn for Upcoming Movie Release Data
-
Positive Earnings Trends Heading into 2025, S&P 500 Price Targets Rolling In
-
Another Soft Year for Secondaries: Changes on the Way in 2025?
-
MoneyFM: US Markets Wrap: Will tech stocks hit record high in December?